A. D. Beadell Investment Counsel, Inc. Pfizer Inc Transaction History

A. D. Beadell Investment Counsel, Inc.

$131 Million
Q2 2025

A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 51,161 shares of PFE stock, worth $1.22 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

51,161

Previous 50,161 1.99%

Holding current value

$1.22 Million

Previous $1.27 Million 2.44%

% of portfolio

0.95%

Previous 1.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$21.59 - $24.84 $21,590 - $24,840	1,000 Added 1.99%	51,161 $1.24 Million
Q1 2025 Apr 11, 2025	BUY	$25.01 - $27.13 $73,779 - $80,033	2,950 Added 6.25%	50,161 $1.27 Million
Q4 2024 Jan 10, 2025	BUY	$24.8 - $30.19 $83,700 - $101,891	3,375 Added 7.7%	47,211 $1.25 Million
Q3 2024 Oct 09, 2024	BUY	$27.7 - $31.39 $440,430 - $499,101	15,900 Added 56.92%	43,836 $1.27 Million
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $59,487 - $69,708	2,355 Added 9.21%	27,936 $781,000
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $66,019 - $75,811	2,550 Added 11.07%	25,581 $709,000
Q4 2023 Jan 18, 2024	BUY	$26.13 - $33.94 $364,905 - $473,972	13,965 Added 154.04%	23,031 $663,000
Q1 2023 Apr 12, 2023	BUY	$39.39 - $51.28 $146,845 - $191,171	3,728 Added 69.84%	9,066 $369,000
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $34,897 - $41,377	-750 Reduced 12.32%	5,338 $279,000
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $34,832 - $51,633	-843 Reduced 12.16%	6,088 $359,000
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $31,400 - $40,336	-800 Reduced 10.35%	6,931 $298,000
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $30,272 - $34,293	843 Added 12.24%	7,731 $302,000
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $6,350 - $7,450	-200 Reduced 2.82%	6,888 $252,000
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $73,872 - $105,548	-2,733 Reduced 27.83%	7,088 $231,000
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $827,312 - $938,894	-25,131 Reduced 71.9%	9,821 $384,000
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $92,596 - $120,070	-2,850 Reduced 7.54%	34,952 $1.26 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $14,644 - $16,441	-396 Reduced 1.04%	37,802 $1.64 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $30,375 - $33,372	-810 Reduced 2.08%	38,198 $1.62 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $116,525 - $132,851	-3,029 Reduced 7.21%	39,008 $1.7 Million
Q2 2018 Jul 19, 2018	SELL	$32.98 - $35.16 $103,886 - $110,753	-3,150 Reduced 6.97%	42,037 $1.53 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $131,628 - $152,707	-4,125 Reduced 8.37%	45,187 $1.6 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $23,282 - $24,703	-700 Reduced 1.4%	49,312 $1.79 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $1.55 Million - $1.71 Million	50,012	50,012 $1.79 Million

Others Institutions Holding PFE

# of Institutions

3,358

Shares Held

3.6B

Call Options Held

104M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $134B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.

Account

A. D. Beadell Investment Counsel, Inc. Pfizer Inc Transaction History